Top Markets
Coin of the day
Bright Minds Biosciences Inc. Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc.

DRUG
Classement en actions #11319
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics... Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company’s BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.
Prix de l'action
$73.12
Dernière synchronisation: 2026-08-28
Capitalisation boursière
$715.61M
Changement (1 jour)
-1.90%
Changement (1 an)
88.01%
Pays
US
Échange Bright Minds Biosciences Inc. (DRUG)

Catégorie

Historique du prix de l'action pour Bright Minds Biosciences Inc. (DRUG)
Prix de clôture le plus élevé : $78.82 le 2026-08-01

Prix de clôture le plus bas : $26.78 le 2021-03-01
Historique du prix de l'action de Bright Minds Biosciences Inc. de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -9.92%
2025 104.69%
2024 2,591.40%
2023 -68.68%
2022 -73.75%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH